Table 4 Multivariate survival analysis of clinicopathological findings and expression of molecular markers
From: Significance of CD133 expression in esophageal squamous cell carcinoma
| Â | Variables | Hazard ratio | 95% confidence interval | P |
|---|---|---|---|---|
Overall survival | pStageIII/IV | 2.64 | 1.42-5.03 | 0.0020 |
Lymphatic invasion positive | 1.48 | 0.79-2.89 | 0.23 | |
CD133 negative | 1.74 | 0.94-3.35 | 0.078 | |
Disease-free survival | Male | 2.09 | 0.84-6.99 | 0.12 |
| Â | Cervix/upper | 2.51 | 1.07-5.21 | 0.035 |
| Â | pStageIII/IV | 2.93 | 1.62-5.42 | 0.0004 |
| Â | CD133 negative | 1.73 | 0.96-3.24 | 0.071 |